GlassScriptPhysician profile
Jillian M Lloyd
NPI 1699919886
$1,222.09
in general payments reported to CMS, 2019-2025
31 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $80.96 · 2022: $59.38 · 2023: $298 · 2024: $336 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $840.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $154.04 | 2023 | Hemoblast Bellows |
| Merck Sharp & Dohme LLC | $136.11 | 2022-2025 | Keytruda, Lynparza |
| Hologic Sales and Service, LLC | $99.59 | 2024 | Localizer, Trident Specimen Radiography System |
| Genentech USA, INC. | $83.31 | 2023-2025 | Perjeta, Phesgo, Polivy |
| Abbvie INC. | $79.40 | 2019-2020 | |
| Boston Scientific Corporation | $50.98 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $50.90 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $49.10 | 2023 | |
| Puma Biotechnology, INC. | $45.97 | 2024 | |
| Lilly USA, LLC | $39.60 | 2022-2025 | Verzenio |
| Stryker Corporation | $38.55 | 2025 | Molli, Eikon Lt Adapt Smoke Evacuation |
| Teleflex LLC | $35.63 | 2025 | Quikclot |
| Siemens Medical Solutions USA, INC. | $32.18 | 2023 | Mammomat Revelation |
| Daiichi Sankyo INC. | $31.92 | 2024 | Enhertu |
| Myriad Genetic Laboratories, INC. | $26.52 | 2022-2023 | Myrisk |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $22.48 | 2025 | Surgiflo Hemostatic Matrix, Ethicon, Vistaseal |
| Janssen Biotech, INC. | $20.69 | 2019 | |
| Caris Mpi, INC. | $20.06 | 2025 | Mi Cancer Seek |
| Polynovo North America LLC | $19.27 | 2024 | Novosorb Btm |
| Covidien LP | $19.01 | 2019 | |
| Kerecis Limited | $17.50 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Amgen INC. | $16.76 | 2019 | |
| Pfizer INC. | $16.69 | 2024 | |
| Solventum Corporation | $16.47 | 2024 | Prevena, Prevena Restor Bellaform |
| Tactile Systems Technology INC | $16.17 | 2020 | |
| Incyte Corporation | $15.46 | 2019 | |
| Seagen INC. | $15.02 | 2022 | |
| Eisai INC. | $14.45 | 2020 | |
| Allergan, INC. | $13.83 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.02 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Lloyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.